Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using a digital tool to improve shoulder pain treatment in rural areas

Official title: Assessment of Rural Health Care: Introduction of the TRAK Digital Tool for Quality and Accessible Medical Care

Run by Trak Health Solutions S.L. · NCT06796309 · Data updated 2026-11-12

This study is testing if a digital tool called TRAK can help people in rural areas with shoulder pain get better treatment and feel more satisfied compared to regular at-home exercises.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment95 (estimated)
SponsorTrak Health Solutions S.L.
Industry-sponsored
Locations1 site (Madrid)
StatusRecruiting
StartedFebruary 7, 2024
Main results expectedMay 1, 2025
Study endsMay 1, 2025
Registry record updatedApril 8, 2025
Trial IDNCT06796309 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include seniors with shoulder pain lasting more than six months who have access to the necessary technology and internet.

Probably not a fit

Patients with cognitive impairments may not benefit from this study due to the requirement of using the TRAK digital tool.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the usability and satisfaction of healthcare personnel and patients in rural areas using the TRAK tele-rehabilitation tool for shoulder pain. Participants will be randomly assigned to either an experimental group receiving telerehabilitation through the TRAK platform or a control group following a conventional at-home exercise protocol. The study will assess the effectiveness of the TRAK tool over an eight-week period, with participants completing health assessments and satisfaction questionnaires before and after the intervention. The goal is to enhance the quality and accessibility of rehabilitation services in rural settings.

Why it matters

Potential benefit: If successful, this study could provide a more effective and accessible rehabilitation option for patients suffering from shoulder pain in rural areas.

How similar studies have gone: Other studies have shown promising results with tele-rehabilitation approaches, indicating potential success for this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria population 1:

* They carry out their activity in a rural environment.
* That they know how to use the tool.
* That they have a device with which to use the tool.
* That they have an e-mail address.
* That they have an Internet connection.
* That they have signed the informed consent form.

Exclusion Criteria population 1:

* N/A

Inclusion Criteria population 2:

* Seniors.
* Patients with omalgia of more than 6 months of evolution.
* Who have a device with which to use the tool.
* Who have a device with which to use the tool.
* Who have an Internet connection.
* Who have an e-mail address.
* Who have signed the informed consent form.

Exclusion Criteria population 2:

* Patients with cognitive impairment.

Where it's running

  • Hospital Universitario del Sureste
    Madrid, Spain
    Recruiting

Study contacts

  • Principal investigator: Ana Vadillo Cortázar — Hospital Universitario del Sureste
  • Study coordinator: Juan F Duarte Mendoza
  • Email: juanfernando@trak.es
  • Phone: +34 677 33 4869

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.